Thanks for sharing Bell Potters' note @Anjo-Roch
I find the note had quite a few interesting points, in particular "we believe there is positive read through from the LVAD trial for the larger Phase 3 trial" - hold on, didnt the market write it off as a total failure and negative impact on phase 3 trial? Pffff - What would these analysts know?
PT $4.03 - I can live with that, until partnerships are signed
Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-51
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.000(0.00%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.440M | 1.107M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7276 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 28124 | 12 |
View Market Depth
| Last trade - 15.16pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |